CALA

Calithera Biosciences Inc. (CALA) | Rumor.io

Calithera Biosciences

CALA

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization1.5K

Earnings per share-3.97

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-39.6M

Social

What share of all stock conversation is about CALA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 10

$CALA is a token that supports animal welfare by providing food and rescue for stray cats.
A portion of the project's proceeds fuels real-world impact, supporting shelters and funding spay-and-neuter programs.
Holding $CALA contributes to making a difference for animals in need, with every transaction contributing to cat rescue efforts worldwide.

Generated by AI

Sentiment

Of the messages about CALA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +60
Bearish	—	—	—	0% -60

Bullish· Feb 21

The community's engagement and virality surrounding $CALA is driving a massive launch, with 50M tokens successfully distributed and a strong focus on community and real engagement.
$CALA's launch on the TON blockchain is expected to benefit from fast, low-cost transactions and seamless Telegram integration, setting the stage for a successful and scalable project.
The pace of growth and adoption of $CALA is impressive, with many users expressing bullish sentiment and eagerness to participate in the project's future developments and potential moonshot.

Bearish· Jan 10

Calithera Biosciences, Inc. ($CALA) is facing lawsuits and potential management misconduct.
The company's decision to burn through cash reserves for management salaries has led to significant losses for shareholders.
The liquidation of assets and dissolving of the company will result in shareholders losing their investments, with the holders of convertible preferred shares receiving the remaining cash and assets.

Generated by AI

Topics

Of the messages about CALA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· Aug 7

Calithera Biosciences, Inc. ($CALA) reported better-than-expected earnings with a loss of $0.09, compared to the expected loss of $0.32.
The company's Q2 2018 earnings call is scheduled for 05:00 PM, with a live and on-demand option available.
The call will provide insight into the company's performance and future prospects.

Announcements· Jan 10

Calithera Biosciences, Inc. announces publication of data showing potential impact of bucillamine on COVID-19 Omicron variants.
The publication is a key milestone for the company, highlighting the therapeutic potential of bucillamine.
The announcement is likely to be of interest to investors in the biotech sector, particularly those following Calithera Biosciences.

Generated by AI

Community

Of the messages about CALA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	20%
Newcomers	—	—	—	80%

Regulars· Jan 10

Calithera Biosciences Inc. has been trending on social media, with the company's stock symbol $CALA mentioned in posts.
Revive Therapeutics, a competitor of Calithera Biosciences, has announced a publication showing bucillamine's potential impact on COVID-19 Omicron variants.
Calithera Biosciences Inc. has secured a contract with a large healthcare network client in Florida, adding 34 new hospital clients to its iUGO Care platform.

Newcomers· Jan 10

The company plans to dissolve and liquidate its assets, which may lead to a decrease in stock value.
There is a possibility that put options may be a good bet due to the company's decision.
The news was announced by Calithera Biosciences, Inc. (Nasdaq: CALA) yesterday.

Generated by AI

Also Discussed

Investors talking about CALA also mention

#	Name	Attention
1	AFMD - Affimed N.V.	——
2	Palvella Therapeutics IncPIRS	0%0
3	BLCM - Bellicum Pharmaceuticals, Inc.	——
4	RDUS - Radius Recycling, Inc.	——
5	Cellectis S.A. ADRCLLS	0%new
6	Agios Pharmaceuticals, Inc.AGIO	0%0
7	MACK - Merrimack Pharmaceuticals, Inc.	——
8	XOMA CorporationXOMA	0%0
9	Exelixis Inc.EXEL	0%-0.03
10	Incyte Corp.INCY	0%new

Calithera Biosciences Inc.

Financial Services
Shell Companies

Calithera Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule compounds, primarily in the field of tumor biology. Its primary function involves discovering and advancing therapeutic candidates that can potentially address various cancer-related challenges. The company operates within the biotechnology sector, specifically targeting precision oncology. Although it has transitioned into a plan of liquidation, historically, Calithera Biosciences Inc. contributed to advancements in cancer treatment through innovative small molecule therapies. Headquartered in South San Francisco, California, the company was founded in 2010 and played a role in shaping the landscape of cancer research.

Website

Location

343 Oyster Point Boulevard

South San Francisco, CA, 94080

United States

Social

What share of all stock conversation is about CALA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 10

$CALA is a token that supports animal welfare by providing food and rescue for stray cats.
A portion of the project's proceeds fuels real-world impact, supporting shelters and funding spay-and-neuter programs.
Holding $CALA contributes to making a difference for animals in need, with every transaction contributing to cat rescue efforts worldwide.

Generated by AI

Sentiment

Of the messages about CALA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +60
Bearish	—	—	—	0% -60

Bullish· Feb 21

The community's engagement and virality surrounding $CALA is driving a massive launch, with 50M tokens successfully distributed and a strong focus on community and real engagement.
$CALA's launch on the TON blockchain is expected to benefit from fast, low-cost transactions and seamless Telegram integration, setting the stage for a successful and scalable project.
The pace of growth and adoption of $CALA is impressive, with many users expressing bullish sentiment and eagerness to participate in the project's future developments and potential moonshot.

Bearish· Jan 10

Calithera Biosciences, Inc. ($CALA) is facing lawsuits and potential management misconduct.
The company's decision to burn through cash reserves for management salaries has led to significant losses for shareholders.
The liquidation of assets and dissolving of the company will result in shareholders losing their investments, with the holders of convertible preferred shares receiving the remaining cash and assets.

Generated by AI

Topics

Of the messages about CALA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Earnings· Aug 7

Calithera Biosciences, Inc. ($CALA) reported better-than-expected earnings with a loss of $0.09, compared to the expected loss of $0.32.
The company's Q2 2018 earnings call is scheduled for 05:00 PM, with a live and on-demand option available.
The call will provide insight into the company's performance and future prospects.

Announcements· Jan 10

Calithera Biosciences, Inc. announces publication of data showing potential impact of bucillamine on COVID-19 Omicron variants.
The publication is a key milestone for the company, highlighting the therapeutic potential of bucillamine.
The announcement is likely to be of interest to investors in the biotech sector, particularly those following Calithera Biosciences.

Generated by AI

Community

Of the messages about CALA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	20%
Newcomers	—	—	—	80%

Regulars· Jan 10

Calithera Biosciences Inc. has been trending on social media, with the company's stock symbol $CALA mentioned in posts.
Revive Therapeutics, a competitor of Calithera Biosciences, has announced a publication showing bucillamine's potential impact on COVID-19 Omicron variants.
Calithera Biosciences Inc. has secured a contract with a large healthcare network client in Florida, adding 34 new hospital clients to its iUGO Care platform.

Newcomers· Jan 10

The company plans to dissolve and liquidate its assets, which may lead to a decrease in stock value.
There is a possibility that put options may be a good bet due to the company's decision.
The news was announced by Calithera Biosciences, Inc. (Nasdaq: CALA) yesterday.

Generated by AI

Calithera Biosciences

Social

Mar 10

Sentiment

Bullish· Feb 21

Bearish· Jan 10

Topics

Earnings· Aug 7

Announcements· Jan 10

Community

Regulars· Jan 10

Newcomers· Jan 10

Also Discussed

Calithera Biosciences Inc.

Company Information

Location

Also Discussed

Social

Mar 10

Sentiment

Bullish· Feb 21

Bearish· Jan 10

Topics

Earnings· Aug 7

Announcements· Jan 10

Community

Regulars· Jan 10

Newcomers· Jan 10